Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors

Published:2014-10-23 Issue:6 Volume:5 Page:517-524
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Chang Hyun¹²,Zhang Xianglan³,Cho Byoung Chul²,Park Hee Jin⁴,Kim Joo-Hang²

Affiliation:

1. Division of Hematology and Medical Oncology; Department of Internal Medicine; International St. Mary's Hospital; Incheon Korea

2. Department of Internal Medicine; Yonsei University College of Medicine; Seoul Korea

3. Department of Pathology; Yanbian University Hospital; Yanji China

4. Department of Pathology; Yonsei University College of Medicine; Seoul Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12122/fullpdf

Reference30 articles.

1. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

2. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations;Sequist;J Clin Oncol,2008

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer;Clinical Lung Cancer;2019-01

2. A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer;Oncology;2018

3. EGF Induced RET Inhibitor Resistance inCCDC6-RETLung Cancer Cells;Yonsei Medical Journal;2017

4. EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy;OncoTargets and Therapy;2016-08